Pau Romera Romero

Mr. Pau Romera Romero

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2022 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Closed access
PRPau Romera Romero
Pau Romera Romero
SDS. Duch
S. Duch
JMJ. Moreno-Montañés
J. Moreno-Montañés
JGJ. Botella García
J. Botella García
MMM. Balboa Miró
M. Balboa Miró
JAJ. Loscos Arenas
J. Loscos Arenas

3 April 2020 in Case Reports in Ophthalmology
Verified
Journal Article
Open access
PDF file
PAPablo Diaz Aljaro
Pablo Diaz Aljaro
JAJordi Loscos Arenas
Jordi Loscos Arenas
LILaura Broc Iturralde
Laura Broc Iturralde
MPMarc Carbonell Puig
Marc Carbonell Puig
PRPau Romera Romero
Pau Romera Romero
We report a case of ocular decompression retinopathy (ODR) with macular edema, diagnosed by optical coherence tomography, after a deep sclerectomy (DS) with an intrascleral implant, resolved with medical therapy 6 months later. The medical literature reports that in 14% of patients suffering from ODR, a pars plana vitrectomy was required, and 15% of patients had a poor final visual acuity. An otherwise healthy 75-year-old man with high myopia and a primary open-angle glaucoma, with previous intraocular pressure (IOP) of 24 mm Hg, underwent a DS with intrascleral implant without complications. The patient suffered postoperatively from ODR with macular edema that required medical therapy with nonsteroidal anti-inflammatory eye drops (Nepafenac® 0.3%) for a period of 6 months. ODR is an infrequent complication that may occur after any surgical or medical procedure that causes a sudden IOP decrease. The presence of macular edema is only reported in 5% of cases and can occur in patients who report a decreased visual acuity, commonly associated with a retinal hemorrhage. We have described a case of ODR with macular edema after DS with intrascleral implant. Although ODR is considered to cause a low level of morbidity, in some patients this may not be the case.

28 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RJRachid Bouchikh El Jarroudi
Rachid Bouchikh El Jarroudi
ABAlina-Dana Baxant
Alina-Dana Baxant
PSPavel Studeny
Pavel Studeny
KFKolbe Roche Fernández
Kolbe Roche Fernández
ASAdrián Sánchez-Fortún Sánchez
Adrián Sánchez-Fortún Sánchez
PRPau Romera Romero
Pau Romera Romero
Objective: The objective was to provide evidence on the effectiveness (intraocular pressure, IOP) and safety of Deep Sclerectomy with the Esnoper Clip implant with and without the use of mitomycin C (MMC) in uncontrolled primary open-angle glaucoma. Methods: This was a multicentric, retrospective, consecutive case series study undertaken as a collaboration between University Hospital Trias i Pujol, Spain, and University Hospital Kralovske Vinohrady, Czech Republic. The IOP reduction was compared between patients who underwent Deep Sclerectomy with the Esnoper Clip implant, where the antifibrotic agent mitomycin C was used perioperatively (MMC group), and patients who underwent Deep Sclerectomy with Esnoper Clip implants where mitomycin C was not used either peri- or postoperatively (non-MMC group). At the end of the study (12 months after surgery), complete success probability (defined as an IOP <21 mmHg without medication) and qualified success probability (defined as an IOP <21 mmHg with or without medication) were assessed. Safety was based on postoperative complications. A descriptive and exploratory analysis was performed. Results: Between January 2017 and June 2019, a total of 72 consecutive patients (40 women and 32 men; age [median (range)] 70 (39–90)) with uncontrolled primary open-angle glaucoma who underwent Deep Sclerectomy with an Esnoper Clip implant were included. Of these, 78 eyes were included: 44 eyes (38 patients) in the MMC group and 34 eyes (34 patients) in the non-MMC group. At the end of the study (38 and 32 eyes, respectively), the complete success probabilities (95% confidence interval) were 62.2% (51.5–75.2%) and 80.5% (69.5–93.2%), p-value: 0.001; qualified success probability (95% confidence interval): 84.7% (76.6–93.7%) and 85.7% (75.8–97%), p-value: 0.188; and complications (total): 36 and 24, p-value: 0.286. Conclusions: In this case series study, the use of mitomycin C in Deep Sclerectomy with the Esnoper Clip implant for patients with uncontrolled primary open-angle glaucoma does not appear to improve IOP one year after surgery. No safety issues related to mitomycin C were observed. Further study is needed to confirm the effectiveness and to assess long-term safety.

1 April 2025 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
RJRachid Bouchikh El Jarroudi
Rachid Bouchikh El Jarroudi
KFKolbe Roche Fernández
Kolbe Roche Fernández
PRPau Romera Romero
Pau Romera Romero
TCTatiana Croitoru-Croitoru
Tatiana Croitoru-Croitoru
AGAnna Goñi-Guarro
Anna Goñi-Guarro
SVSebastian Videla
Sebastian Videla
Introduction: There are no available data concerning corneal parameters in patients with chronic ocular hypotony. Our purpose is to provide evidence and clinical correlation on the biomechanical corneal changes in chronic hypotonic eyes. Patients and Methods: A single-center, transversal, self-controlled case series study was conducted involving patients with at least one chronic hypotonic eye (defined as an intraocular pressure ≤ 6.5 mmHg measured on three separate occasions for at least three months). The chronic hypotonic eye was the case and the contralateral eye the control (non-hypotonic eye). We collected data from baseline characteristic and intraocular pressure (mmHg). Biomechanical corneal parameters measured by Corvis ST: deformation amplitude ratio (mm), Ambrósio’s relational thickness (μm), stiffness parameter at first applanation (mmHg/mm), Integrated radius (mm− 1), stress-strain index, pachymetry (μm), and in addition macular folds were recorded as well. A descriptive and exploratory analysis was performed. Results: Between November 2021 and July 2023, a total of 16 consecutive patients (7 men, 9 women; age [median (range)]: 72 (62– 84)), diagnosed with chronic ocular hypotony in one eye were included: 16 chronic hypotonic eyes and 16 non-hypotonic eyes. Hypotonic versus non-hypotonic eyes [median (range)]: intraocular pressure: 4 (2– 6) mmHg, 16 (8– 38) mmHg; deformation amplitude ratio: 5.6 (4.3– 6.6) mm, 4.7 (3.9– 5.5) mm, p-value= 0.002; Ambrósio’s relational thickness: 482 (263– 932) μm, 530 (210– 818) μm, p-value: 0.845; stiffness parameter at first applanation: 61.5 (39– 100) mmHg/mm, 113 (68– 130) mmHg/mm, p-value: < 0.001; Integrated radius: 10.9 mm− 1 (6.3– 16.8), 7.9 mm− 1 (6.4– 10.5), p-value: < 0.001; stress-strain index: 0.7 (− 0.2– 4.9), 1.1 (− 2.7– 5.6), p-value: 0.034; pachymetry 509 (456– 617) μm, 512 (436– 775) μm, p-value: 0.637; and macular folds: 7/16, 0/16, p-value: < 0.001. Conclusions: Chronic hypotonic eyes (eyes with a low intraocular pressure) present biomechanical corneal changes with respect to non-hypotonic eyes, mainly in deformation amplitude ratio, stiffness parameter at first applanation, stress-strain index and Ambrósio’s relational thickness parameters. These biomechanical corneal changes could reflect softer, more elastic and deformable scleras, which at its turn can bear higher risk of hypotony maculopathy.

1 April 2015 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
PRPau Romera Romero
Pau Romera Romero
ALA. Monés Llivina
A. Monés Llivina
AAA. Blazquez Abisu
A. Blazquez Abisu
ALA. Sabala Llopart
A. Sabala Llopart

30 October 2025 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
PRPau Romera Romero
Pau Romera Romero
JGJ. Botella Garcia
J. Botella Garcia
ASA. Sanchez-Fortun Sanchez
A. Sanchez-Fortun Sanchez
RJR. Bouchikh El Jarroudi
R. Bouchikh El Jarroudi
JAJ. Loscos Arenas
J. Loscos Arenas